This is a randomized double-blind placebo-controlled trial of MHE in patients with cirrhosis
using rifamycin SV-MMX 600mg BID vs placebo for 30 days with PK, safety, microbiota, brain
function and brain MRI endpoints.
Phase:
Phase 2
Details
Lead Sponsor:
Hunter Holmes Mcguire Veteran Affairs Medical Center